Biofrontera Inc. (BFRI) Corporate Subsidiaries
Biofrontera Inc. (BFRI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BFRI
CIK: 1858685
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Cohen
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001493152-26-042508 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037834 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037610 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0001622627-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | 4 | 0001493152-26-035273 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | 4 | 0001493152-26-035271 | View SEC Doc Filr Page |
| S-8 | 2026-07-22 | — | S-8 | 0001493152-26-034268 | View SEC Doc Filr Page |
| 10-K/A | 2026-07-22 | 2025-12-31 | 10-K/A | 0001493152-26-034251 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-11 | 8-K | 0001493152-26-029079 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023119 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001493152-26-022875 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001493152-26-020616 | View SEC Doc Filr Page |
| 10-K | 2026-03-19 | 2025-12-31 | 10-K | 0001493152-26-011625 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-19 | 8-K | 0001493152-26-011545 | View SEC Doc Filr Page |
| 8-K | 2026-03-09 | 2026-03-09 | 8-K | 0001493152-26-009321 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009259 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009257 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009255 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009253 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009251 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009249 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001493152-26-009247 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-23 | 8-K | 0001493152-26-008136 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-11 | — | SCHEDULE 13G/A Filing | 0001622627-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-02-09 | 2026-02-09 | 8-K | 0001493152-26-005717 | View SEC Doc Filr Page |